Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action).
Joanne WilkinsonKhalid Abd-ElazizIzaak den DaasJohan WemerMichiel van HaastertVictoria HodgkinsonMichelle FosterCathal CoylePublished in: Drug development and industrial pharmacy (2018)
These studies demonstrate the effective acid neutralizing capacity of Gaviscon DA versus placebo in healthy, fasted subjects. This adds to the evidence base for the combination of alginates and antacids.